Tianlong COVID-19 Solution Safeguards Passengers In Jakarta International Airport In Indonesia

Xi'an TianLong Science and Technology Co., Ltd

PR95394

 

XI'AN, China, April 8, 2022 /PRNewswire=KYODO JBN/ --

 

Tianlong's integrated PCR lab solution is installed in Jakarta's international

airport in Indonesia to help conduct nucleic acid testing for inbound and

outbound passengers. Since its installation in September 2021, Tianlong's

COVID-19 solution has helped diagnose hundreds of positive cases at the Jakarta

International Airport. Timely entry testing effectively prevents the import of

positive cases from abroad and protects the gateway of Indonesia.

 

https://mma.prnewswire.com/media/1783165/2_ID_1a2149e12028.jpg

 

Since the airport is still a focal point in the global spread of COVID-19, fast

and accurate detection is crucial to stopping the chain of transmission and

evacuate passengers. Tianlong's COVID-19 solution has enhanced the testing

capability of the Jakarta international airport with the report within one and

a half hours, which effectively helps fast isolation and ensures the timely

departure of flights, reducing inconvenience for passengers during the

transition.

 

Tianlong uses the polymerase chain reaction (PCR) method for nucleic acid

detection. With the step of PCR amplification, the result is more accurate.

Tianlong's COVID-19 solution realizes fast and accurate detection with the test

result reporting within one and a half hours, which fully meets the epidemic

prevention and control requirement of airports. Up to 3,000 samples will be

tested in the Jakarta international airport by Tianlong COVID-19 solution per

day.

 

Tianlong is a leading molecular diagnosis products manufacturer in China. We

are doing R&D on nucleic acid extraction and detection devices and reagents.

Since the outbreak of the COVID-19 pandemic, Tianlong's products have helped

over 60 countries fight against the pandemic, such as Indonesia, Denmark, the

UAE. Our products have helped local facilities build up the health care system

and fast diagnose COVID-19 patients. Tianlong's anti-epidemic products have

been a star in the war against COVID-19. Apart from the COVID-19 solution,

Tianlong has reagents covering 200 kinds of disease detection. We will bring

technology to life and provide more solutions to better care for people

globally.

 

Explore Tianlong: https://www.tlgenetech.cn/

 

Follow us on:

LinkedIn: https://www.linkedin.com/company/tianlongbiotech

Facebook: https://www.facebook.com/TianlongBiotech/

Twitter: https://twitter.com/TianlongBiotech

 

Contact us:

inquiry@medtl.com

+86-29-82682132

 

Source: Xi'an TianLong Science and Technology Co., Ltd

 

Image Attachments Links:

 

   Link: http://asianetnews.net/view-attachment?attach-id=418780

 

   Caption: Tianlong's engineer is giving training in Jakarta International Airport

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中